{"nctId":"NCT00641108","briefTitle":"Effects of Cognitive Behavioral Therapy on Brain Serotonin Activity in People With Depression","startDateStruct":{"date":"2008-01"},"conditions":["Depression"],"count":30,"armGroups":[{"label":"ADAM SPECT","type":"EXPERIMENTAL","interventionNames":["Drug: ADAM SPECT plus Cognitive Therapy"]},{"label":"Control","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: ADAM SPECT plus No Therapy"]}],"interventions":[{"name":"ADAM SPECT plus Cognitive Therapy","otherNames":[]},{"name":"ADAM SPECT plus No Therapy","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* DSM-IV diagnosis of major depressive disorder (MDD)\n* Drug naive from prior psychotropic medication for more than 6 months before study entry\n* Hamilton-Depression (HAM-D) 17 score greater than or equal to 16\n* Woman of childbearing age with a negative pregnancy test within 48 hours of scanning\n\nExclusion Criteria:\n\n* DSM-IV Axis I diagnosis other than MDD\n* Use of psychotropic medication within 6 months of study entry\n* History of bipolar disorder\n* Current alcohol or drug abuse/dependence within 6 months of study entry\n* History of sensitivity or intolerance to s-citalopram\n* Medical contraindication to the use of s-citalopram\n* Unstable medical condition (e.g., angina pectoris, untreated hypertension)\n* Pregnant or nursing\n* Woman of childbearing potential not using a medically acceptable form of birth control\n* Actively suicidal or requiring hospitalization\n* Requiring additional psychotropic drug therapy\n* History of transient ischemic attacks\n* History of cerebral infarction (including lacunar infarct with symptoms more than 24 hours in duration)\n* History of Binswanger's disease or a history of hypertensive encephalopathy\n* History of intracranial hemorrhage\n* History of head trauma with loss of consciousness\n* History of encephalitis\n* History of extended exposure to known neurotoxin (e.g., cyanide, carbon monoxide)\n* Uncontrolled metabolic disorder (e.g., thyroid disease, diabetes mellitus)\n* History of cognitive impairment other than major depressive episode\n* History of normal pressure hydrocephalus\n* History of cancer metastatic to the central nervous system\n* History of Parkinson's or other basal ganglia disease\n* History of Guillain-Barr√© syndrome (chronic or relapsing polyneuropathy)\n* Inability to undergo an MRI scan","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","maximumAge":"65 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in Serotonin Transporter Availability","description":null,"classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":0},"commonTop":[]}}}